conclusions the data from this cohort indicates that most of patients diagnosed with hcc present at late tumor and liver disease stages, when prognosis is usually dismal. regular cancer surveillance in cirrhotic patients might change the outcomes. further studies with results of treatment outcomes in this community are needed. background hepatocellular carcinoma (hcc) is one of the leading caus...

conclusions cd5l might be a useful biomarker for early diagnosis of hcc in hcv cirrhotic patients. lrg and hp α2 isoforms could be potential markers for distinguishing viral hcc. our results also further support the presence of varying molecules involved in hepatocarcinogenesis in hbv when compared with hcv infection. patients and methods two-dimensional polyacrylamide gel electrophoresis combi...

conclusions hbv and hcv are important culprits of hcc in emro countries and the middle east and different nations need different strategies to tackle them accordingly. countries with high rates of hbv such as turkey should continue their hbv vaccination and also increase sanitation. nations with high hcv rates such as egypt should maintain their blood product monitoring in addition to increased...